Impact of suspected adverse drug reactions on mortality and length of hospital stay in the hospitalised patients: a meta-analysis
- 18 November 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 79 (1), 99-116
- https://doi.org/10.1007/s00228-022-03419-7
Abstract
Purpose To estimate the risk of mortality and length of stay in hospitalised patients who have experienced suspected adverse drug reactions (ADRs) as compared to patients who did not experience suspected ADRs. Methods A systematic literature search was conducted on databases for observational and randomised controlled studies conducted in any inpatient setting that reported deaths and/or length of hospital stay in patients who had suspected ADRs and did not have suspected ADRs during hospitalisation. PRISMA guidelines were strictly followed during the review. The methodological quality of included studies was assessed using a tool designed by Smyth et al. for the studies of adverse drug reactions. The meta-analytic summary of all-cause mortality was estimated using odds ratio—OR (95% CI) and length of stay using mean difference—MD (95% CI). Both outcomes were pooled using a random effect model (DerSimonian and Laird method). Subgroup and meta-regression were performed based on study variables: study design, age group, study ward, study region, types of suspected ADRs (ADRAd—suspected ADRs that lead to hospitalisation and ADRIn—suspected ADRs that occur following hospitalisation), study duration, sample size and study period. The statistical analysis was conducted through the ‘Review manager software version 5.4.1 and JASP (Version 0.14.1)’. Results After screening 475 relevant articles, 55 studies were included in this meta-analysis. Patients having suspected ADRs had reported significantly higher odds of all-cause mortality [OR: 1.50 (95% CI: 1.21–1.86; I2 = 100%) than those patients who did not have suspected ADRs during hospitalisation. Study wards, types of suspected ADRs and sample size were observed as significant predictors of all-cause mortality (p < 0.05). Patients having suspected ADRs had reported significantly higher mean difference in hospital stay [MD: 3.98 (95% CI: 2.91, 5.05; I2 = 99%) than those patients who did not have suspected ADRs during hospitalisation. Types of suspected ADRs and study periods were observed as significant predictors of length of stay (p < 0.05). Conclusion Suspected ADRs significantly increase the risk of mortality and length of stay in hospitalised patients. Systematic review registration. CRD42020176320.Keywords
This publication has 81 references indexed in Scilit:
- The increased risks of death and extra lengths of hospital and ICU stay from hospital-acquired bloodstream infections: a case–control studyBMJ Open, 2013
- Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions – A Meta-AnalysisPLOS ONE, 2012
- Adverse Drug Reactions in Children—A Systematic ReviewPLOS ONE, 2012
- Trends in Length of Stay and Short-term Outcomes Among Medicare Patients Hospitalized for Heart Failure, 1993-2006JAMA, 2010
- The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialtyBMC Clinical Pharmacology, 2009
- Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-EpisodesPLOS ONE, 2009
- Incidence, severity and preventability of medication-related visits to the emergency department: a prospective studyCMAJ : Canadian Medical Association Journal, 2008
- Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational studyBritish Journal of Clinical Pharmacology, 2007
- Detecting Adverse Drug Reactions on Paediatric WardsDrug Safety, 2005
- Readmissions and adverse drug reactions in internal medicine: the economic impactJournal of Internal Medicine, 2004